View in EDS

EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France.

Saved in:
Bibliographic Details
Title: EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France.
Authors: Boussahoua, M1 (AUTHOR), Sutherland, CS2 (AUTHOR), Aponte Ribero, V3 (AUTHOR), Enache, R4 (AUTHOR), Le Lay, K4 (AUTHOR), Le Dissez, C4 (AUTHOR), Chevalier, J1 (AUTHOR)
Source: Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS87-S87. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2022.09.423